Sodium Phenyl Butyrate DC Granules – Advanced Direct Compression Technology for Metabolic Disorder Therapy
Sodium Phenyl Butyrate DC Granules – Advanced Direct Compression Technology for Metabolic Disorder Therapy By Swapnroop Drugs & Pharmaceuticals ππ Sodium Phenyl Butyrate (CAS No. 1716-12-7) is an essential therapeutic agent used primarily for managing Urea Cycle Disorders (UCDs) . Its role in detoxifying ammonia makes it a life-saving medication for patients with compromised nitrogen elimination pathways. However, the API alone is known to have challenges related to taste, stability, hygroscopicity, and poor flow properties . To address these issues, Sodium Phenyl Butyrate DC Granules offer a superior, ready-to-compress solution ideal for efficient pharmaceutical manufacturing. At Swapnroop Drugs & Pharmaceuticals , we specialize in producing high-performance DC granules with excellent stability, compressibility, and uniformity—designed for reliable therapeutic formulations. π§ͺ What Are Sodium Phenyl Butyrate DC Granules? Sodium Phenyl Butyrate DC G...